Study Investigating Whether Robot-assisted Surgery Can Reduce Surgical Complications Following Kidney Transplantation
ORAKTx
Open-label Randomized Clinical Trial Investigating Whether Robot-Assisted Kidney Transplantation Can Reduce Surgical Complications Compared to Open Kidney Transplantation; The ORAKTx Trial
2 other identifiers
interventional
106
1 country
2
Brief Summary
The purpose of this study is to explore whether robot-assisted surgery can reduce 30-day surgical complications compared to open surgery in kidney transplantation. Participants are adult recipients of kidney transplantation. Upon entry into the trial participants will be randomly assigned eiher open kidney transplantation or robot-assisted kidney transplantation. The participants in both groups will be treated in accordance with up-to-date guidelines and care. Our hypothesis is that robot-assisted surgery can reduce vascular complications by 15% and/or major surgical complicatons by 20% within 30 days of kidney transplantation compared to open surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2023
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2023
CompletedFirst Posted
Study publicly available on registry
February 15, 2023
CompletedStudy Start
First participant enrolled
May 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 26, 2027
ExpectedDecember 9, 2025
October 1, 2025
2.5 years
February 7, 2023
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Vascular complications
Composite outcome consisting of a) bleeding requiring reoperation, b) renal/graft vascular thrombosis, c) symptomatic hematomas d) renal/graft arterial stenosis
30 days after surgery
Surgical complications Clavien-Dindo >grade 2
All postoperative complications will be recorded and graded according to the Clavien-Dindo classification with major complications defined as \>grade 2.
30 days after surgery
Secondary Outcomes (26)
Length of Stay (LOS)
12 months
Days Alive and Out of Hospital (DAOH)
30 days after surgery
Days Alive and Out of Hospital (DAOH)
90 days after surgery
Quality of Life (QOL): SF-36
30 days after surgery
Quality of Life (QOL): SF-36
90 days after surgery
- +21 more secondary outcomes
Study Arms (2)
Robot-assisted Kidney Transplantation (RAKT)
EXPERIMENTALParticipants will undergo standard work-up prior to transplantation according to the KDIGO guidelines, in addition, participation in the study will require a non-contrast CT of the abdomen to exclude severe calcification of the iliac vessels. Participants will be managed according to the standard protocol for renal transplantation at Rigshospitalet and will follow standard pre-, peri- and post-operative care aside from operating modality. The anaestethic protocol will be tailored to suit robot-assisted surgery
Open Kidney Transplantation (OKT)
ACTIVE COMPARATORParticipants will undergo standard work-up prior to transplantation according to the KDIGO guidelines, in addition, participation in the study will require a non-contrast CT of the abdomen to exclude severe calcification of the iliac vessels. Participants will be managed according to the standard protocol for anaesthesia and renal transplantation at Rigshospitalet and will follow standard pre-, peri- and post-operative care aside from operating modality.
Interventions
Robot-Assisted Kidney Transplantation takes place with the patient under general anaesthesia. Several ports are placed in the lower abdomen, for the entry of the camera, surgical instruments and manuel access. The DaVinci robot is placed between the patient's legs and docked to the ports. The iliac vascular bed is prepared and a peritoneal cavity created laterally. The kidney is introduced through the handport, regional hypothermia obtained via iceslush in the cavity and the vessel lumens flushed with heparin. The vessels are blocked during suturing with the kidney graft vessels anastomosed end-to-side to the external iliac vessels. The kidney graft is placed in the retroperitoneal cavity and a ureterovesical anastomosis performed ad modem Woodruff over double J stent. The ureter is placed extra peritoneally, fascia closed in layers and the skin using intracutaneous suturing. Perioperative prophylactics entail piperacillin/tazobactam and an indwelling bladder catheter is placed.
Open Kidney Transplantation takes place with the patient under general anaesthesia. A jockey-stick (Gibson) incision is made in the left or right iliac fossa and the peritoneum is displaced. With the kidney under hypothermia, the iliac vascular bed is prepared, the vessel lumens flushed with heparin and a vascular clamp instrument is used to block the vessels during suturing. The kidney graft vessels are anastomosed end-to-side to the external iliac vessels and the ureterovesical anastomosis performed ad modem Woodruff over a double J stent. The kidney graft is placed in the cavity and the fascia is closed in layers and the skin using intracutaneous suturing. Perioperative prophylactics entail piperacillin/tazobactam and an indwelling bladder catheter is placed.
Eligibility Criteria
You may qualify if:
- Adult recipients for renal transplantation
- Both patients in dialysis as well as pre-emptive
You may not qualify if:
- High degree of calcification of the iliac vessels on the level of external iliac artery defined as occurrence of longitudinal plaques on non-contrast CT-scan or other relevant radiological imaging in recipient prior to transplantation
- Highly complex vascular anatomy in the donor kidney requiring multiple anastomoses as evaluated by surgeon
- Previous kidney transplantation with later allograft nephrectomy as evaluated by the surgeon preoperatively
- Patients whose abdominal anatomy may prohibit access to and placement of graft in the iliac fossa as evaluated by the surgeon preoperatively (i.e. previous laparotomy, rectal surgery, herniotomy, current multiple kidney cysts)
- Simultaneous multiple organ transplant
- Severe comorbidities contraindicating robot-assisted surgery
- Patients who are unable to understand relevant medical information and the implications of treatment alternatives and to make an independent, voluntary decision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Urological Research Unit, Rigshospitalet
Copenhagen, N, 2200, Denmark
Department of Nephrology, Rigshospitalet
Copenhagen, Ă˜, 2100, Denmark
Related Publications (1)
Ortved M, Dagnaes-Hansen J, Stroomberg HV, Kistorp T, Rohrsted M, Sorensen SS, Roder A. Open-label randomised clinical trial investigating whether robot-assisted kidney transplantation can reduce surgical complications compared to open kidney transplantation (ORAKTx): study protocol for a randomised clinical trial. Trials. 2025 Jan 6;26(1):8. doi: 10.1186/s13063-024-08706-5.
PMID: 39762978DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreas Roeder, MD, PhD
Rigshospitalet, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 7, 2023
First Posted
February 15, 2023
Study Start
May 8, 2023
Primary Completion
October 26, 2025
Study Completion (Estimated)
October 26, 2027
Last Updated
December 9, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
All study data including study protocol, statistical analysis plan, informed consent form, and clinical study report can be shared when a proper agreement is formed according to the European Union (EU) General Data Protection Regulation (GDPR) protection statement.